We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MAIN:NYSEMain Street Capital Corporation Analysis

Data as of 2026-07-10 - not real-time

$52.84

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Main Street Capital (MAIN) trades around $52.84, well above its DCF‑derived fair value of roughly $9.83, indicating a substantial premium. The stock’s valuation metrics reinforce this view: a trailing P/E of 11.1 versus an industry average of 17.6 and a dividend yield of 8.48% backed by a high payout ratio of about 90% of earnings. Technical signals are mixed – the price sits below its 20‑day (51.36) and 50‑day (52.03) SMAs, the 200‑day SMA sits at 57.0, and the MACD histogram is positive, yet the broader trend is flagged as bearish with a 30‑day volatility of 18% and a max drawdown of –26.5%.
Recent operational highlights include a $319 million addition to the private‑loan portfolio in Q2 2026 and a $46.4 million realized gain from an equity exit, underscoring the firm’s active deal‑making. However, the balance sheet shows a hefty debt load ($2.54 billion) and a debt‑to‑equity ratio above 80, while operating cash flow remains negative. These fundamentals, combined with the elevated price, suggest the stock is currently overvalued and may face pressure unless earnings and cash generation improve.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Price significantly above DCF fair value
  • Bearish technical trend and proximity to resistance
  • High dividend payout ratio relative to cash flow

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Attractive dividend yield if income focus
  • Continued loan‑portfolio growth and recent realized gains
  • Elevated leverage and uncertain cash‑flow sustainability

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Business‑development model offers diversified exposure to lower‑middle‑market companies
  • Potential for steady income if dividend policy stabilizes
  • Valuation premium may persist, requiring earnings improvements to justify price

Key Metrics & Analysis

Financial Health

Revenue Growth2.20%
Profit Margin74.86%
P/E Ratio11.1
ROE14.37%
ROA5.58%
Debt/Equity82.11
P/B Ratio1.6
Op. Cash Flow$-163850000
Free Cash Flow$238.9M
Industry P/E17.6

Technical Analysis

TrendBearish
RSI58.4
Support$49.43
Resistance$53.37
MA 20$51.36
MA 50$52.03
MA 200$57.00
MACDBullish
VolumeStable
Fear & Greed Index94.59

Valuation

Fair Value$9.83
Target Price$57.33
Upside/Downside8.50%
GradeOvervalued
TypeValue
Dividend Yield8.48%

Risk Assessment

Beta0.77
Volatility18.02%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.